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Green LA, Yi R, Petrusca D, Wang T, Elghouche A, Gupta SK,
Petrache I, Clauss M. HIV envelope protein gp120-induced apopto-
sis in lung microvascular endothelial cells by concerted upregulation
of EMAP II and its receptor, CXCR3. Am J Physiol Lung Cell Mol
Physiol 306: L372–L382, 2014. First published December 6, 2013;
doi:10.1152/ajplung.00193.2013.—Chronic lung diseases, such as
pulmonary emphysema, are increasingly recognized complications of
infection with the human immunodeficiency virus (HIV). Emphysema
in HIV may occur independent of cigarette smoking, via mechanisms
that are poorly understood but may involve lung endothelial cell
apoptosis induced by the HIV envelope protein gp120. Recently, we
have demonstrated that lung endothelial apoptosis is an important
contributor to the development of experimental emphysema, via
upregulation of the proinflammatory cytokine endothelial monocyte-
activating polypeptide II (EMAP II) in the lung. Here we investigated
the role of EMAP II and its receptor, CXCR3, in gp120-induced lung
endothelial cell apoptosis. We could demonstrate that gp120 induces
a rapid and robust increase in cell surface expression of EMAP II and
its receptor CXCR3. This surface expression occurred via a mecha-
nism involving gp120 signaling through its CXCR4 receptor and p38
MAPK activation. Both EMAP II and CXCR3 were essentially
required for gp120-induced apoptosis and exposures to low gp120
concentrations enhanced the susceptibility of endothelial cells to
undergo apoptosis when exposed to soluble cigarette smoke extract.
These data indicate a novel mechanism by which HIV infection
causes endothelial cell loss involved in lung emphysema formation,
independent but potentially synergistic with smoking, and suggest
therapeutic targets for emphysema prevention and/or treatment.
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INDIVIDUALS CHRONICALLY INFECTED with HIV have an increased
incidence of developing several lung complications, including
emphysema, pulmonary hypertension, and lung cancer (6, 9,
23, 26, 28, 33). Interestingly, development of emphysema
often occurs at an earlier age in HIV patients (i.e., 20–40 yr)
than in non-HIV positive smokers (i.e., 50–70 yr), independent
of cigarette smoking status (6, 8, 9). Because emphysema
carriers a high morbidity and mortality, identifying the deter-
mining factors involved in HIV-induced emphysema is of great
importance.
The HIV envelope protein gp120 has been shown to have
several effects on endothelial cells, most notably induction of
apoptosis (10, 15, 18). Apoptosis has been shown to be caspase
and p38 MAPK dependent and mediated by the gp120 receptor
CXCR4 in various endothelial cell types (25, 41, 42). With
regards to lung pathology, gp120 has been shown to increase
ceramides, which can induce oxidative stress and apoptosis of
endothelial cells leading to the development of emphysema
(34). In addition to increased endothelial cell apoptosis, em-
physema is characterized by variable levels of lung inflamma-
tion. In this context, we and others have shown that gp120, in
synergy with cytokines, activates endothelial cells to release
chemokines and to express vascular adhesion molecules (13,
16), further augmenting an inflammatory response.
Recently, we have demonstrated that a molecular link be-
tween excessive endothelial apoptosis and inflammation,
which is significantly involved in the development of cigarette
smoke-induced emphysema in mice, is the release of the
proinflammatory cytokine endothelial monocyte-activating
polypeptide II (EMAP II) (5). Interestingly, cigarette smoke
exposure leads to the concerted upregulation of EMAP II and
its chemokine receptor CXCR3 in mouse lungs and in primary
human lung microvascular endothelial cells, a pathway leading
to apoptosis (5, 14).
EMAP II is an intracellular protein, which is transported to
the cell surface and released in response to various stresses
including hypoxia, mechanical strain, apoptosis, TNF-, and
cigarette smoke (2, 24, 27, 32). Here we investigated if the HIV
envelope protein gp120 induces apoptosis in lung microvascu-
lar cells via EMAP II and its receptor, CXCR3, independent of
cigarette smoke exposure. We show that gp120 signaling
through its coreceptor, CXCR4, and p38 MAPK signaling
leads to a rapid surface expression of EMAP II and CXCR3.
This concerted upregulation of EMAP II and CXCR3 is essen-
tial for gp120-induced apoptosis, suggesting a novel autocrine/
paracrine mechanism of endothelial cell apoptosis in HIV
infection.
MATERIALS AND METHODS
Reagents and cells. Anti-CXCR3 (MAB160) and CXCR4 (MAB170)
were obtained from R&D Systems. AlexaFluor secondary antibodies
and Tempol were from Invitrogen. p38 MAPK inhibitor (SB203580)
was purchased from Sigma. Recombinant EMAP II and monoclo-
nal neutralizing antibodies to EMAP II were produced and purified
as recently described (34, 37). Adult human lung microvascular
endothelial cells (HLMVEC; Clonetics, Lonza) were cultured in
EGM2MV media. CXCR4-tropic recombinant HIV gp120 was
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purchased from Immunodiagnostics (Woburn, MA) and derived
from CHO cells.
Determination of CXCR3 and EMAP II by flow-assisted cytometric
analysis. Flow-assisted cytometric analysis (FACS) was performed as
previously described (36). Briefly, HLMVEC (1  106) were fixed in
1% paraformaldehyde (PFA) and stained with anti-human CXCR3 or
EMAP II antibodies and the appropriate secondary antibodies. In
some cases, HLMVEC were permeabilized with 0.01% Triton X-100
in PBS and stained again using the same primary but different
secondary antibodies to detect intracellular CXCR3 or EMAP II. Cells
were then analyzed with a FACS-Calibur flow cytometer (BD), and
fold induction was calculated based on isotype controls.
Determination of total and surface CXCR3 and EMAP II by
immunofluorescence microscopy. HLMVEC were fixed in 1% PFA
and stained with CXCR3 (Clone 220803; R&D Systems; 1:100) or
EMAP II (1:200) followed by incubation with secondary antibody
[Alexa Fluor(r) 546 goat anti-mouse IgG and Alexa Fluor(r) 546 goat
anti-rabbit IgG; Invitrogen; 1:1,000]. In some case, HLMVEC were
then permeabilized with 0.01% Triton X-100 in PBS to detect intra-
cellular CXCR3 or EMAP II. Confocal microscopy (Olympus
FV1000-MPE)-derived images were analyzed using MetaMorph soft-
ware.
Detection of apoptosis by assessing DNA fragmentation (terminal
deoxynucleotidyl transferase-mediated dUTP nick end labeling) and
annexin V/PI. Apoptosis was assessed by terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL Apoptosis
Detection Kit; Millipore) in attached endothelial cells as previously
described (37). Briefly, images were analyzed by MetaMorph image
software, and results were expressed by computing the ratios between
TUNEL-positive and total (DAPI positive) cells. Detection of apop-
tosis by measuring DNA fragmentation via FACS was also carried out
using a fluorescein labeling system to detect dUTP end nicks accord-
ing to the manufacturer’s instructions (APO-BRDU kit; Becton Dick-
inson).
For detection of apoptosis by annexin V, cells were stained using
the BD Pharmingen PE annexin V apoptosis detection kit according to
the manufacturer’s instructions.
p38 MAP kinase silencing in endothelial cells with small interfer-
ing RNA. For p38 gene knockdown by RNAi we used Ambion’s
Silencer Select Custom Designed small interfering (si)RNA against
p38 using a protocol as previously described (38). Briefly, cells were
transfected with Lipofectamine 2000 transfection reagent (Invitrogen)
and after incubation for 2 days at 37°C, total cell lysate was used to
determine the knockdown of p38 by Western blotting.
Determination of p38 MAP kinase phosphorylation by Western
blot. Cells were lysed in cell lysis buffer (no. 9803S; Cell Signaling;)
containing protease inhibitor cocktail (no. 88663; ThermoScientific)
with protein concentrations determined by BCA assay. Proteins (20
ng) were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), followed by immunoblotting using
phospho-p38 or GAPDH antibodies. The chemiluminescent signals
were quantified by densitometry using Adobe Photoshop.
Cigarette smoke extract preparation. Filtered research-grade ciga-
rettes (1R3F) from the Kentucky Tobacco Research and Development
Center (University of Kentucky, Lexington, KY) were used for
preparing aqueous cigarette smoke extract (100%) as previously
described (4). Briefly, smoke from two cigarettes or air (ambient air
controls) was blown into 20 ml of PBS, followed by pH adjustment to
7.4- and 0.2-m filtration.
Statistical analysis. Each experiment was performed in triplicate,
with a minimum of three independent experiments. The differences
between groups were compared using paired Student’s t-test (for
Fig. 1D and Fig. 2E) or ANOVA with Bonferroni corrections (for all
others). Where applicable, means  SE of multiple measurements are
reported as indicated.
RESULTS
gp120 Induces CXCR3 and EMAP II surface expression.
Based on our previous finding that stresses can increase
CXCR3 receptor surface upregulation in endothelial cells (14),
we wanted to know whether HIV envelope (gp120) would have
the same ability. Therefore, we treated human microvascular
endothelial cells (HMVEC) with recombinant gp120 for up to
18 h and then determined surface CXCR3 expression by flow
cytometry (Fig. 1, A and B). We found that recombinant gp120
induced rapid upregulation of CXCR3 surface expression as
early as 3 h after addition of gp120 and remained high for 18
h. To confirm the membrane upregulation of CXCR3, we
examined CXCR3 expression in unpermeabilized and perme-
abilized HMVEC and found that the ratio of extracellular to
total CXCR3 was increased dramatically (Fig. 1, C and D)
while total expression of CXCR3 remained unchanged, indi-
cating that increased surface CXCR3 expression is due to
protein trafficking rather than overall increased protein synthe-
sis.
To explore the possibility that CXCR3 upregulation was
accompanied by induction of its ligand, EMAP II, we then
examined the expression of EMAP II in HMVEC after expo-
sure to gp120. We found a two- to threefold increase in surface
EMAP II after only 3 h of exposure, followed by a gradual
reduction to basal levels over 18 h (Fig. 2, A and B). The
decrease of EMAP II surface expression was accompanied by
a corresponding increase in EMAP II released in the superna-
tant, as determined by EMAP II ELISA (Fig. 2C), suggesting
active EMAP II secretion from endothelial cells in response to
gp120. We then confirmed upregulation by determining the
ratio of extracellular to total EMAP II. We compared EMAP II
expression in unpermeabilized and permeabilized HMVEC and
found that the ratio of surface to total EMAP II increases
significantly after gp120 treatment, suggesting that EMAP II
surface upregulation is due to increased transport of EMAP II
to the membrane surface (Fig. 2, D and E).
CXCR3 and EMAP II expression mediate gp120-induced
endothelial apoptosis. Next, we determined whether the con-
certed upregulation of CXCR3 and EMAP II led to a corre-
sponding increase of apoptosis. Using a FACS-based TUNEL
assay, we analyzed apoptosis in HMVEC treated with either
gp120 alone or with a combination of gp120 and EMAP II.
Interestingly, while gp120-induced endothelial apoptosis alone
was very robust and highly significant, we observed further
increase in apoptosis when additional EMAP II (Fig. 3A) was
added, suggesting that gp120-induced upregulation of the
EMAP II CXCR3 receptor apoptosis is involved. Indeed, the
addition of CXCR3 neutralizing antibodies abolished gp120-
induced endothelial apoptosis (Fig. 3B). Importantly and in line
with gp120-induced upregulation of EMAP II surface expres-
sion described above, neutralizing antibodies to EMAP II also
abrogated gp120-induced endothelial apoptosis (Fig. 3C) sug-
gesting that concerted induction of EMAP II and its receptor
CXCR3 by gp120 is responsible for gp120-induced endothelial
apoptosis. To confirm induction of apoptosis by gp120, we
then determined apoptosis by annexin V staining and found a
similar increase in apoptosis (Fig. 3D).
Signal transduction analysis of gp120-induced endothelial
apoptosis. p38 MAPK has been previously implicated in
gp120-induced apoptosis. In addition, both p38 and reactive
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oxygen species are implicated in cigarette smoke-induced en-
dothelial cell injury and apoptosis (14). Therefore, we focused
on the role these signal transduction relays. We used a specific
p38 MAPK inhibitor or the SOD mimetic Tempol, which we
have previously demonstrated to inhibit cigarette smoke in-
duced apoptosis and CXCR3 induction, respectively. Inhibi-
tion of p38 MAPK potently blocked gp120-induced apoptosis.
However, Tempol failed to have an effect on gp120-induced
apoptosis (Fig. 3C), suggesting that gp120 may have both
shared and distinct signaling pathways required for apoptosis
compared with cigarette smoking.
Signal transduction analysis of gp120-induced CXCR3 and
EMAP II expression. To determine if p38 MAPK upregulation
was upstream of gp120-induced EMAP II and CXCR3 surface
upregulation, we incubated HMVEC with gp120 for 4 h in the
presence of p38i or Tempol and then measured CXCR3 (Fig. 4A) or
EMAP II (Fig. 4B) surface expression by FACS. While Tem-
pol did not have an effect on CXCR3 upregulation, it did
provide a slight inhibition of EMAP II upregulation. In con-
trast, p38 inhibition caused a marked decrease in the amount of
both surface CXCR3 and EMAP II expression, suggesting that
p38 is involved in both the upregulation of CXCR3 and EMAP
II by gp120.
Differential analysis of p38 MAPK in gp120-induced CXCR3/
EMAP II expression and apoptosis. To distinguish between the
involvement of p38 MAPK in the gp120-induced upregulation of
CXCR3/EMAP II from its role in CXCR3-mediated apoptosis
induction (35), we added a p38 MAPK inhibitor (SB203580)
Fig. 1. Upregulation of CXCR3 by gp120. A and B: human lung microvascular endothelial cells (HMVEC) were treated with 100 ng/ml gp120 for the indicated
time points, then stained for surface CXCR3, and analyzed by flow cytometry. Data are expressed as fold CXCR3 expression, normalized to IgG controls.
A: representative histogram. C: extracellular (top) and total (bottom) CXCR3 was determined before and after 3-h gp120 treatment (100 ng/ml). D: surface
expression of CXCR3 was determined before and after gp120 treatment and expressed as percent of total expression.
L374 GP120 INDUCES APOPTOSIS THROUGH EMAP II AND CXCR3
AJP-Lung Cell Mol Physiol • doi:10.1152/ajplung.00193.2013 • www.ajplung.org







immediately upon addition of gp120, or after 4 h of treatment with
gp120, sufficient for CXCR3 and EMAP II upregulation, and then
determined apoptosis. Consistent with the hypothesis that p38 is
involved in both CXCR3 upregulation and CXCR3 apoptosis
signaling, p38 inhibition abolished apoptosis at both early and late
time points (Fig. 5A). To confirm the involvement of p38 in
gp120-induced apoptosis, we transfected HMVEC with p38
siRNA or scrambled control siRNA and determined gp120-in-
duced apoptosis after knockdown of p38. In fact, we found no
induction of apoptosis after p38 knockdown, while cells trans-
fected with scrambled control siRNA maintained strong apoptosis
(Fig. 5B). Next we analyzed p38 MAPK activation after treatment
with gp120 by Western blot analysis of HMVEC. This analysis
indicated biphasic p38 phosphorylation and activation, with an
initial peak after 30 min of gp120 treatment and a second peak
around 16 h after addition of gp120 (Fig. 5, C and D).
Fig. 2. Upregulation of endothelial monocyte-activating polypeptide II (EMAP II) by gp120. A and B: HMVEC were treated with 100 ng/ml gp120 for the
indicated time points and then stained for surface EMAP II and analyzed by flow cytometry. Data are expressed as fold EMAP II expression, normalized to IgG
controls. A: representative histogram. C: supernatants were collected for all time points and EMAP II concentration was determined by ELISA (Antigenix,
Huntington Station, NY). D: extracellular (top) and total (bottom) EMAP II was determined before and after 3-h gp120 treatment (100 ng/ml). E: surface
expression of EMAP II was determined before and after gp120 treatment and expressed as percentage of total expression.
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CXCR4 mediates gp120-induced CXCR3 and EMAP II ex-
pression but is not directly responsible for gp120-induced
apoptosis induction. In immune cells gp120 signals via a main
receptor, CD4, and two coreceptors, CXCR4 and CCR5. En-
dothelial cells do not express CD4; however, they do express
CXCR4 in small amounts, a receptor that has been previously
established to mediate gp120-induced endothelial apoptosis
(25, 41, 42). We therefore treated HMVEC with gp120 in the
presence of CXCR4 neutralizing antibodies and determined
CXCR3 and EMAP II surface upregulation. The CXCR4
neutralizing antibody completely abolished gp120-induced
both CXCR3 (Fig. 6A) and EMAP II (Fig. 6B) upregulation,
whereas a control IgG had no effect. Next, we tested the effect
of CXCR4 neutralizing antibody to gp120-induced apoptosis.
In contrast to p38 inhibitors, the anti-CXCR4 antibody only
inhibited apoptosis when included at the same time as gp120
Fig. 3. EMAP II and CXCR3 are required for gp120-induced apoptosis. HMVEC were treated with 100 ng/ml gp120 alone or in combination with EMAP II
(30 g/ml; A), neutralizing antibodies to EMAP II (3.5 g/ml) and CXCR3 (1 g/ml; B), or p38 inhibitor SB203580 (10 g/ml) and Tempol (6 mM; C) for
22 h. Apoptosis was determined by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining and normalized to untreated
controls. D: detection of apoptosis was determined by annexin V staining after 22-h gp120 treatment and normalized to untreated controls (representative
histogram top panel).
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(Fig. 6C). Altogether, these data confirm our overall model of
two stages, in which CXCR4 is required in the early first stage
of gp120-induced endothelial apoptosis to upregulate CXCR3
and EMAP II. Once CXCR3 and EMAP II are upregulated
they are sufficient to trigger apoptosis in a gp120 and CXCR4-
independent manner.
Cigarette smoke extract enhances gp120-induced apoptosis
induction. Because of the high prevalence of smoking in the
HIV-positive population and the established role of cigarette
smoke in lung emphysema development, we determined
whether cigarette smoke exposure had a synergistic or
additive effect with gp120 on endothelial cells. This is
particularly relevant because of the earlier onset of emphy-
sema in HIV-positive patients, suggesting the possibility
that gp120 can provoke an increased susceptibility to to-
bacco damage. We treated HMVEC with concentrations of
gp120 that were insufficient to induce apoptosis of endothe-
lial cells alone, along with an established concentration of
cigarette smoke extract (14), and found that gp120 enhanced
cigarette smoke-dependent apoptosis in a dose-dependent
manner (Fig. 7).
DISCUSSION
Our data suggest a mechanism for the observed ability of
the HIV envelope to induce endothelial cell death (10, 15, 18,
25, 41, 42). According to our two-step model (see Fig. 8), gp120
activates first the CXCR4 receptor to induce concerted upregu-
lation of proapoptotic EMAP II and its receptor CXCR3. In
step 2 EMAP II and its receptor CXCR3 induce p38 MAPK-
dependent apoptosis. This is in line with our previous demon-
stration that cigarette smoke also induces upregulation of
EMAP II and its CXCR3 receptor leading to endothelial
apoptosis even in nonproliferating endothelial cells (5, 14).
Intriguingly, endothelial cell death has been suggested as an
important mechanism to induce lung emphysema in rodents
(11, 21, 34, 39) and humans (20), and lung capillary endothe-
lial cell injury and apoptosis may explain the increased inci-
dence of emphysema in HIV-infected patients (33).
There are several lines of evidence in support of our
hypothesis that the HIV envelope can evoke a series of
events including EMAP II/CXCR3 upregulation to induce
endothelial apoptosis and vascular injury during develop-
ment of pulmonary emphysema. First, HIV-infected cells
appeared adjacent to emphysematous areas of lung while
normal appearing areas were devoid of infected cells, sug-
gesting that infected cells could potentially directly cause
lung damage (43). Secondly, injected HIV virus in small
rodents suggested endothelial dysfunction in the cardiopul-
monary system including oxidative stress and upregulation
of proinflammatory cytokines, similar to what is observed in
humans with HIV infections (1). Together with reports that
gp120 can cause endothelial apoptosis (15, 41), we postulate
that gp120 induction of endothelial apoptosis could be a
mechanism for the increased incidence of emphysema ob-
served in HIV infected patients. Our previous work has
revealed EMAP II as an important mediator of emphysema
development, which was able to link inflammation, a hall-
mark in human emphysema, to tissue destruction. Indeed,
treatment with an EMAP II neutralizing antibody inhibited
the development of cigarette smoke-induced emphysema in
mice (5). Additionally, prolonged upregulation of secreted
EMAP II in the lung of a transgenic model led to increased
cell death in lung structural cells, including endothelial
cells, an accumulation of monocytes, upregulation of matrix
metalloproteinases, and an increase in airspace, which, al-
together, correlate with features of pulmonary emphysema
in humans (5). Interestingly, we could reduce excess up-
regulation of EMAP II in this model using broad range
caspase inhibitors, a finding that is in line with the hypoth-
esis that apoptosis further upregulates EMAP II release,
resulting in a feed-forward loop and further destruction of
alveolar compartments. Based on these results, we propose
that gp120-induced endothelial apoptosis and EMAP II-
Fig. 4. Signal transduction of CXCR3 and EMAP II surface upregulation.
HMVEC were treated with 100 ng/ml gp120 for 4 h in combination with
p38 inhibitor SB203580 (10 g/ml) and Tempol (6 mM) and then stained
for surface CXCR3 (A) or EMAP II (B). Data are expressed as fold
expression and normalized to IgG controls.
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CXCR3 signaling could lead to inflammation by recruiting
mononuclear phagocytes and eliciting positive feedback loops by
inducing endothelial apoptosis, a mechanism known to release
further amounts of intracellular EMAP II (24).
In this study, we used a gp120 concentration of 100
ng/ml, which has been previously established to induce
endothelial cell death and to be relevant for modeling in
vivo exposures of cells to HIV (25). Our finding that
gp120-induced upregulation of CXCR3 is time dependent is
in line with what we have observed previously with cigarette
smoke-induced CXCR3 upregulation. On the other hand,
gp120-induced upregulation of EMAP II surface expression
is biphasic, with a late decrease, which was accompanied by
a significant increase in free EMAP II released in the
supernatant, consistent with a scenario wherein intracellular
EMAP II is first externalized at the membrane surface and
then released, causing an autocrine and potentially paracrine
response. The mechanism of EMAP II membrane binding
and release is unknown. It is possible this mechanism is
similar to the alternative release of FGF1, whereby several
proteins including S100A13 and synaptotagmin 1, form a
membrane-associated protein complex that mediates the
flip-flop from intracellular to extracellular membrane local-
ization (12, 17, 22). The apparently delayed release of
surface bound EMAP II may be a result of such a mecha-
nism with yet unknown binding partners.
Fig. 5. Involvement of p38 in gp120-induced apoptosis. A: HMVEC were treated with 100 ng/ml gp120 for 22 h, with p38 inhibitor SB203580 (10 g/ml) added
either immediately upon addition of gp120 (0 h) or after 4 h (4 h) of treatment. Apoptosis was determined by TUNEL staining and normalized to untreated
controls. B: HMVEC were transfected with p38 small interfering (si)RNA or control scrambled siRNA and tested for p38 expression at 2 days posttransfection
by Western blot (inset). Cells were then treated with gp120 and apoptosis was determined by TUNEL staining and normalized to mock transfected control cells.
C: HMVEC were treated with 100 ng/ml gp120 for the indicated time points and then cell lysates were subjected to phospho-p38 Western blot. C: densitometry
analysis of phospho-p38 was normalized to GAPDH loading controls.
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Notably, the degree of difference between the ratio of
extracellular to total CXCR3 and EMAP II (Fig. 1, C and D, vs.
Fig. 2, D and E) is most likely a result of the large intracellular
pool of EMAP II (40). This also explains the high basal level
of EMAP II observed in the supernatant even in unstimulated
HMVEC (Fig. 2C). This large intracellular pool of EMAP II
allows for significant release of EMAP II due to the minor
stress conditions associated with tissue culture. In fact, it is
typically not possible to detect an increase in supernatant
EMAP II in vitro. Because of this, upregulation of CXCR3 is
the rate-limiting step in in vitro EMAP II/CXCR3 apoptosis.
However, the fact that we see an additional increase in released
EMAP II over this initial high level is very telling and likely
indicative of an even greater fold increase in vivo.
While it has been known that gp120 induces apoptosis of
multiple types of endothelial cells, the mechanism for this
observations has not been established other than a known
requirement for CXCR4. Because of our experience with
EMAP II-induced apoptosis of endothelial cells, we thought it
is likely that gp120-dependent apoptosis was mediated through
EMAP II/CXCR3 signaling, and indeed, blocking either
EMAP II or CXCR3 completely abolished gp120-induced
apoptosis. Our findings that gp120 upregulates EMAP II and
CXCR3 and that gp120-dependent apoptosis requires EMAP II
signaling through CXCR3 is indirectly supported by previous
reports that gp120 apoptosis is caspase driven and involves
mitochondrial dysfunction, since CXCR3-dependent apoptosis
is also caspase dependent.
Fig. 6. Involvement of CXCR4 in gp120-induced
apoptosis. HMVEC were treated with 100 ng/ml
gp120 for 4 h alone or in combination with neutral-
izing anti-CXCR4 antibodies (1 g/ml) then stained
for either CXCR3 (A) or EMAP II (B). Data are
expressed as fold CXCR3/EMAP II expression, nor-
malized to IgG controls. C: HMVEC were treated
with 100 ng/ml gp120 for 22 h, with neutralizing
anti-CXCR4 antibodies (1 g/ml) added either im-
mediately upon addition of gp120 (0 h) or after 3 h
(3 h) of treatment. Apoptosis was determined by
TUNEL staining and normalized to untreated con-
trols.
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To further analyze the signaling mechanism for upregulation
of CXCR3 and EMAP II compared with endothelial apoptosis,
we had added candidate inhibitors previously shown to be
involved in cigarette smoke-induced CXCR3 upregulation and
apoptosis induction, at early and late time points. Intriguingly,
independent of the time point of application, p38 MAP kinase
inhibitors were able to both block CXCR3 upregulation and
apoptosis. This finding is in line with previous reports that p38
activation is downstream of CXCR4 signaling and essential for
CXCR3-mediated apoptosis (19, 30). Our Western blot analy-
sis of p38 phosphorylation further supports this, as we ob-
served an initial peak shortly after addition of gp120, consis-
tent with the initial activation of the CXCR4 receptor, and a
second peak after 16 h of gp120 treatment, consistent with
apoptosis signaling through CXCR3 (see Fig. 8 for scheme)
(7). In contrast, inhibition of reactive oxygen species using a
SOD-mimetic inhibited neither CXCR3 upregulation nor apo-
ptosis, which is distinct from signaling employed by cigarette
smoke to upregulate CXCR3.
According to demographic information, there is a high
prevalence of cigarette smoke exposure in the HIV-positive
population (3, 29, 31). Although the risk of emphysema
development in HIV patients appears higher than the risk
posed by cigarette smoke alone, it is possible there is a
synergistic effect between the two risk factors. Our results
support the hypothesis that such a relationship may exist,
since low concentrations of gp120 enhanced the induction of
apoptosis in cigarette smoke exposed endothelial cells. Fu-
ture studies will have to identify the molecular underpin-
nings of such a synergy; however, it is very likely that this
synergy is a result of the differing pathways involved in
CXCR3 upregulation. Because of the contrast between the
available intracellular pools of EMAP II and CXCR3, the
surface expression of CXCR3 is the key step in EMAP
II/CXCR3-mediated endothelial apoptosis. Therefore, the
use of two distinct pathways to mediate CXCR3 surface
expression would allow for a faster response time and
subsequently a greater amount of apoptosis.
In conclusion, these mechanistic insights into the gp120-
induced autocrine and possibly paracrine proapoptotic and
proinflammatory effects involving CXCR3 and EMAP II re-
lease may lead to the development of therapeutics targeting
emphysema and other diseases caused by endothelial damage
in the HIV-infected population.
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Fig. 7. Gp120 increases apoptosis in combination with cigarette smoke.
HMVEC were treated with 10 or 20 ng/ml gp120 for 22 h alone or in
combination with 1% cigarette smoke extract (CSE) or ambient air controls
(AC). Apoptosis was determined by TUNEL staining.
A
B
Fig. 8. Schematic for gp120-induced apoptosis. A: shortly following gp120
binding to its receptor, CXCR4, p38 MAP kinase is activated and induces the
transport of EMAP II and CXCR3 to the cell surface (dashed lines). B: after
surface upregulation, EMAP II signals through CXCR3 to induce apoptosis in
a p38-dependent manner.
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